clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Intense Ultrasound Releases Cancer Biomarkers, Allows for Earlier Cancer Detection
Molecular Dx
Genetic Variant Linked to Cardiovascular Disease and Death in Black Americans
News & Features
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s…
News & Features
Ultra-Low Energy MRI Shows Its Potential
News & Features
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Reimbursing NGS Testing
Reimbursement
Molecular Dx
Reimbursing NGS Testing
Sean Tunis, M.D.
-
January 6, 2015
0
Molecular Dx
Genomic Medicine: Balancing Cost and Value
Alex Philippidis
-
December 10, 2014
0
Molecular Dx
Elements of Change—How Molecular Diagnostics and Histology Will Deliver Growth to U.S. IVD Market
Emil Salazar
-
August 13, 2014
0
1
2
Page 2 of 2
Related Content
Zenas Nets $200M to Advance mAb for Autoimmune Diseases
Novel AI Platform Designs Cancer Drugs to Hit Multiple Targets
Patients of New Doctors with High Board Certification Scores Have Higher Survival Rates
Patient Adverse Events Prevalent in Outpatient Settings
Inside Precision Medicine
![Economic models for evaluating genomic data must consider both the costs and benefits of obtaining the data and delivering the treatments. [© Tameek/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/167.jpeg "Genomic Medicine: Balancing Cost and Value")
